202-140 Columbia St W, Waterloo, ON N2L 3K8, Canada

Call Us: +1 855-885-8288

Bioinformatics Solutions Inc Bioinformatics Solutions Inc
  • Home
  • About Us
    • About Us
    • News
    • Careers
    • Conferences
    • Distributors
  • Products & Services
    • Software Solutions
      • What to Select
      • PEAKS Studio
      • PEAKS Online
      • PEAKS CMD
      • PEAKS AB
      • PEAKS GlycanFinder
    • Proteomics Services
      • Monoclonal Antibody Sequencing
      • Polyclonal Antibody Sequencing Service
      • Immunopeptidome Profiling
      • General Lab Services
    • PEAKS Components
      • de novo Peptide Sequencing
      • PEAKS DeepNovo
      • Database Searching
      • DeepNovo Peptidome
      • DIA Workflow
      • Spectral Library Search
      • PTM Analysis
      • Peptide Mutations (SPIDER)
      • Glycan Analysis
      • Quality Control
      • PEAKS Q (Add-On)
      • PEAKS IMS (Add-On)
    • Purchase Information
      • Pricing Request
      • Service Plan Subscription
  • Free Trial
    • PEAKS Studio Trial
  • Help & Support
    • Technical Notes
      • PEAKS Walkthrough
      • de novo Introduction
      • Database Search Scoring
      • False Discovery Rate
      • Peptide Feature Area
      • Label-Free Quantification
      • Quantification Algorithms
      • SILAC Quantification
    • Self Help
      • Video Tutorials
      • User Manuals
      • Mass Reference
      • Supported Data Formats
      • Versions of PEAKS
      • FAQ
    • Community
      • Workshops
      • Online Training
      • Testimonials
      • User Publications
      • BSI Publications
  • Contact Us
  • Contact Us

Mass spectrometric evidence for neuropeptide-amidating enzymes in C. elegans

0
On 2018-04-202018-10-23By Bioinformatics Solutions IncIn User Publications

Van Bael, S., et al. Mass spectrometric evidence for neuropeptide-amidating enzymes in C. elegans. 293(16), 6052-6063. 20/4/2018.

Protein-based forensic identification using genetically variant peptides in human boneElevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer’s disease

Share this post?

Tweet

Recent Posts

PEAKS Webinar Summit Sessions | Improved Antibody de novo Sequencing by New Features in PEAKS AB 3.5 (November 13, 2024)
Online Training
PEAKS Webinar Summit Sessions | From Discovery to Validation: PEAKS DIA Solutions (October 16, 2024)
Online Training
A novel computational pipeline for immunopeptidomics with DIA-LC-MS/MS
BSI Publications
PEAKS HUPO Breakfast Seminar (October 21, 2024)
Workshop
HUPO 2024 & Breakfast Seminar (October 20–23, 2024)
News
3rd HUPO-HIPP Summer School in Montréal, Quebec (August 14–16, 2024)
News

Socials

  • Facebook
  • LinkedIn
  • Twitter
  • Blogger
  • YouTube

Solutions

  • What to Select
  • PEAKS Studio
  • PEAKS Online
  • PEAKS CMD
  • PEAKS AB Software

Help

  • Online Training
  • Workshops
  • FAQ
  • User Manuals
  • Contact Us

Contact

  • Bioinformatics Solutions Inc.
  • 202-140 Columbia St W
    Waterloo, ON N2L 3K8, Canada
  • Phone: +1 855-885-8288
  • Hours: 9 am – 5 pm Eastern Time
  • Privacy Policy
© 2024 Bioinformatics Solutions Inc.